Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
about
The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intakeEpigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in OffspringSpice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoidsInteraction between Cannabinoid System and Toll-Like Receptors Controls InflammationSchizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura.CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.Synthetic Cannabinoid-Induced Immunosuppression Augments Cerebellar Dysfunction in Tetanus-Toxin Treated Mice.Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cellsTGF-β2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in infarcted myocardium.Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model.Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation.Effects of Cannabinoids on T-cell Function and Resistance to Infection.Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cellsSelective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia.Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activationRNA-seq Analysis of δ9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation.Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNSTransient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice.Do cannabinoids have a therapeutic role in transplantation?The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease.Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or harm?Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.Cannabis, the pregnant woman and her child: weeding out the myths.Involvement of the endocannabinoid system in osteoarthritis pain.Polyunsaturated Fatty Acid-derived lipid mediators and T cell function.Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.Effects of cannabinoids and their receptors on viral infections.Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach.Medical cannabis: Another piece in the mosaic of autoimmunity?Cannabinoids decrease the th17 inflammatory autoimmune phenotype.Polyunsaturated fatty acids and endocannabinoids in health and disease.Potential of Cannabidiol for the Treatment of Viral Hepatitis.Effects of Heavy Drinking on T-Cell Phenotypes Consistent with Immunosenescence in Untreated HIV Infection.High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana.
P2860
Q26850858-CDA66319-D76F-48C9-BD8B-41FFD8535A45Q26864359-CEC68420-7789-4AD7-989E-39C6D1DB7E20Q27010555-8DF7CA8E-B15F-469D-86DA-0E7C0D69A42AQ28066215-A8B71791-1BCB-4453-AF35-1303744A0E59Q30468160-DA405119-75BB-463E-987F-6A5A6D3FE5D7Q30670447-BD89E1C0-C65F-4B1A-BA6A-447FC8E3ED66Q33396602-021E1E22-80E0-4D96-AAA8-2B6C63864A20Q33488512-D197C509-D3B5-4768-999B-26A5F6650A2AQ33655884-41C5F69B-B03E-483B-BC12-75465EF36D8CQ34642592-BABB0B3F-D0CE-4457-97EA-17ADD9366559Q34700334-4553C237-C248-49E3-B5A3-6F2C5BAD477CQ34784627-3A092721-1228-42AB-A95C-EB600C2569BFQ35188151-F42CB5C0-1C6A-4E1F-8326-FAC9161ED3AFQ35193309-B1ADD617-FDAD-47EB-883F-87EDECD9F71AQ35429696-13BB5763-CCD0-400E-A177-D3F4514A5352Q35752103-0C3A5034-D980-48EE-987E-134B2388CA68Q35752185-C8415A80-84A2-4D58-A5EF-337D1856954AQ36176444-B316DC77-1FB7-4CF1-82FA-56EB57D1EFFBQ36347677-A88F6617-6640-4C88-839A-FFAE7B0810B6Q36653699-B7D73D47-8CB5-4433-BCAF-4D20934223A0Q37102278-811A4E59-8F8C-4C60-B308-C9F1138024C6Q37117257-FF017645-2E22-44AD-8475-CFF839D279C9Q37531460-816C61AC-C2A1-482E-9D09-6CB23BE0B7EDQ37648708-396A7B34-2C64-47D4-8B04-A661E2C77DD2Q37768965-AF4F904B-980F-4D96-B61D-7871778251BAQ37988405-2446BBB4-736D-401B-A402-BB4F2FE3A3AAQ38011117-6C804C65-6CFB-4C98-8C8C-ADEB6C17734CQ38087533-E5460D63-C8E6-4E7D-AE76-EC96CBF8AC9AQ38181303-F07A17D6-87E6-4441-BFF1-45D60468BFE3Q38185076-CB9FF9F4-1CE1-455D-8A4F-CB511776C3ADQ38194553-CD38F43A-7B54-4A35-85AD-E2A3698D7F4EQ38220272-08759E42-E335-4E96-B1B3-7B26F656BE51Q38522557-8F734831-34F9-4F78-8C26-755389EB8965Q38615088-EBD2048E-4134-495D-8071-0739D7D3536FQ39012168-EC02FFD1-6D25-4F7C-9AAD-CA48ED321D48Q39119286-EA15494C-AA9B-401B-B0AA-CC4AF82B1D95Q39421016-143ABB65-F87F-4A04-8301-64107F59D615Q40312314-D1A28852-F2DA-4A0E-AF75-6C05253793D4Q40621786-830ABAE5-C96B-4F16-8711-D4EE2414959DQ41434713-D2326CA0-6082-4B20-9CEC-836D39AFC9FC
P2860
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
@en
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
@nl
type
label
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
@en
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
@nl
prefLabel
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
@en
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
@nl
P2093
P2860
P921
P1433
P1476
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
@en
P2093
Ashok Chauhan
Mitzi Nagarkatti
Prakash Nagarkatti
Sadiye Amcaoglu Rieder
Ugra Singh
P2860
P304
P356
10.1016/J.IMBIO.2009.04.001
P577
2009-05-20T00:00:00Z